The commission on human medicines has the function of scrutinizing the efficacy, quality and safety of new drugs before clinical trials and before marketing, as well as the surveillance of each drug after marketing so that adverse reactions are monitored and documented, and warnings issued as required. Early clinical trials of a drug can only be carried out after a clinicaltrial certificate has been issued by the licensing authority.